Intralens is a posterior chamber phakic intraocular lens developed by Mediphacos for the correction of myopia and astigmatism, preserving the natural anatomy and physiology of the eye. Intralens embodies 30 years of accumulated pIOL scientific to provide new levels of safety and clinical performance.

- 4 years of dedicated development work
- 2023 ANVISA regulatory approval (Brazil)
- 30 years of accumulated pIOL evidence
- 40 years of Mediphacos IOL manufacturing

IntraLens Toric is a posterior chamber phakic intraocular lens developed by Mediphacos for the correction of myopia and astigmatism, while preserving the natural anatomy and physiology of the eye. Building on decades of pIOL expertise, IntraLens Toric delivers advanced optical performance, stability, and clinical confidence.

Lens Type: Posterior chamber phakic intraocular lens (pIOL)
Indications: Correction of myopia and astigmatism
Optical Design: Toric design for simultaneous correction of spherical and cylindrical refractive errors
Implantation: Posterior chamber, preserving the natural crystalline lens
Material: Foldable hydrophilic acrylic
Manufacturer: Mediphacos
Regulatory Approval: ANVISA, Brazil – 2023
Clinical Development: 4 years of dedicated development
Scientific Background: 30 years of accumulated pIOL evidence
Manufacturing Expertise: 40 years of Mediphacos IOL manufacturing experience